A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Clinical trial NCT06649045 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06649045
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-22
- Primary completion
- 2026-11-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.